<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34504110</PMID><DateRevised><Year>2021</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2057-3995</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>NPJ Regenerative medicine</Title><ISOAbbreviation>NPJ Regen Med</ISOAbbreviation></Journal><ArticleTitle>Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS.</ArticleTitle><Pagination><StartPage>53</StartPage><MedlinePgn>53</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">53</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41536-021-00161-z</ELocationID><Abstract><AbstractText>Recent double-blind, randomized, controlled trials reported that human umbilical cord-derived mesenchymal stem cell (MSC) infusions in COVID-19 patients with acute respiratory distress syndrome (ARDS) could diminish cytokine storm and lung damage. While these outcomes are significant, additional phase II/III trials are required to validate the efficacy of MSCs to improve the survival of COVID-19 patients with ARDS. Future studies also need to assess the efficacy of MSCs to prevent long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shetty</LastName><ForeName>Ashok K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0001-5049-6671</Identifier><AffiliationInfo><Affiliation>Institute for Regenerative Medicine, Department of Molecular and Cellular Medicine, Texas A&amp;M University College of Medicine, College Station, TX, USA. akskrs@tamu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shetty</LastName><ForeName>Padmashri A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Ramaiah Medical College, Bengaluru, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanirati</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Brain Institute of Rio Grande do Sul (BraIns), Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Kunlin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Neuroscience, University of North Texas Health Science Center Fort Worth, Fort Worth, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS106907</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS106907</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>W81XWH-16-1-0480</GrantID><Agency>U.S. Department of Defense (United States Department of Defense)</Agency><Country/></Grant><Grant><GrantID>W81XWH-14-1-0572</GrantID><Agency>U.S. Department of Defense (United States Department of Defense)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>NPJ Regen Med</MedlineTA><NlmUniqueID>101699846</NlmUniqueID><ISSNLinking>2057-3995</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>10</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34504110</ArticleId><ArticleId IdType="pmc">PMC8429629</ArticleId><ArticleId IdType="doi">10.1038/s41536-021-00161-z</ArticleId><ArticleId IdType="pii">10.1038/s41536-021-00161-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China - key questions for impact assessment. N. Engl. J. Med. 2020;382:692&#x2013;694. doi: 10.1056/NEJMp2000929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2000929</ArticleId><ArticleId IdType="pubmed">31978293</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann-Podczaska A, et al. COVID 19 - clinical picture in the elderly population: a qualitative systematic review. Aging Dis. 2020;11:988&#x2013;1008. doi: 10.14336/AD.2020.0620.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0620</ArticleId><ArticleId IdType="pmc">PMC7390523</ArticleId><ArticleId IdType="pubmed">32765959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi C, et al. World Health Organization declares Global Emergency: a review of the 2019 novel coronavirus (COVID-19) Int. J. Surg. 2020;76:71&#x2013;76. doi: 10.1016/j.ijsu.2020.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2020.02.034</ArticleId><ArticleId IdType="pmc">PMC7105032</ArticleId><ArticleId IdType="pubmed">32112977</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzilai N, et al. Geroscience in the age of COVID-19. Aging Dis. 2020;11:725&#x2013;729. doi: 10.14336/AD.2020.0629.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0629</ArticleId><ArticleId IdType="pmc">PMC7390533</ArticleId><ArticleId IdType="pubmed">32765937</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N. Engl. J. Med. 2020;383:2451&#x2013;2460. doi: 10.1056/NEJMcp2009575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Kox M, Waalders NJB, Kooistra EJ, Gerretsen J, Pickkers P. Cytokine levels in critically ill patients with COVID-19 and other conditions. JAMA. 2020;324:1565&#x2013;1567. doi: 10.1001/jama.2020.17052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17052</ArticleId><ArticleId IdType="pmc">PMC7489366</ArticleId><ArticleId IdType="pubmed">32880615</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng Z, et al. Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11:216&#x2013;228. doi: 10.14336/AD.2020.0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0228</ArticleId><ArticleId IdType="pmc">PMC7069465</ArticleId><ArticleId IdType="pubmed">32257537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271.e8&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern. Med. 2020;180:934&#x2013;943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Demoule A, et al. High-flow nasal cannula in critically iii patients with severe COVID-19. Am. J. Respir. Crit. Care Med. 2020;202:1039&#x2013;1042. doi: 10.1164/rccm.202005-2007LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202005-2007LE</ArticleId><ArticleId IdType="pmc">PMC7528777</ArticleId><ArticleId IdType="pubmed">32758000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanzoni G, et al. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1/2a, randomized controlled trial. Stem Cells Transl. Med. 2021;10:660&#x2013;673. doi: 10.1002/sctm.20-0472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.20-0472</ArticleId><ArticleId IdType="pmc">PMC8046040</ArticleId><ArticleId IdType="pubmed">33400390</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci AS, Lane HC, Redfield RR. Covid-19 &#x2013; navigating the uncharted. N. Engl. J. Med. 2020;382:1268&#x2013;1269. doi: 10.1056/NEJMe2002387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2002387</ArticleId><ArticleId IdType="pmc">PMC7121221</ArticleId><ArticleId IdType="pubmed">32109011</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. Updated approaches against SARS-CoV-2. Antimicrob. Agents Chemother. 2020;64:e00483&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269512</ArticleId><ArticleId IdType="pubmed">32205349</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Tao H, Satyanarayanan SK, Jin K, Su H. A comprehensive summary of the knowledge on COVID-19 treatment. Aging Dis. 2021;12:155&#x2013;191. doi: 10.14336/AD.2020.1124.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.1124</ArticleId><ArticleId IdType="pmc">PMC7801274</ArticleId><ArticleId IdType="pubmed">33532135</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang B, et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: a case report. Medicine. 2020;99:e21429. doi: 10.1097/MD.0000000000021429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000021429</ArticleId><ArticleId IdType="pmc">PMC7402800</ArticleId><ArticleId IdType="pubmed">32756149</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias M, et al. Mesenchymal stem cells for the compassionate treatment of severe acute respiratory distress syndrome due to COVID 19. Aging Dis. 2021;12:360&#x2013;370. doi: 10.14336/AD.2020.1218.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.1218</ArticleId><ArticleId IdType="pmc">PMC7990366</ArticleId><ArticleId IdType="pubmed">33815870</ArticleId></ArticleIdList></Reference><Reference><Citation>Metcalfe SM. Mesenchymal stem cells and management of COVID-19 pneumonia. Med. Drug Discov. 2020;5:100019. doi: 10.1016/j.medidd.2020.100019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medidd.2020.100019</ArticleId><ArticleId IdType="pmc">PMC7147223</ArticleId><ArticleId IdType="pubmed">32296777</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty AK. Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia. Aging Dis. 2020;11:462&#x2013;464. doi: 10.14336/AD.2020.0301.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0301</ArticleId><ArticleId IdType="pmc">PMC7069463</ArticleId><ArticleId IdType="pubmed">32257554</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z, et al. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia. Crit. Care. 2020;14:420. doi: 10.1186/s13054-020-03142-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03142-8</ArticleId><ArticleId IdType="pmc">PMC7351637</ArticleId><ArticleId IdType="pubmed">32653043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SH, Shetty AK, Jin K, Zhao RC. Combating COVID-19 with mesenchymal stem/stromal cell therapy: promise and challenges. Front. Cell. Dev. Biol. 2021;8:627414. doi: 10.3389/fcell.2020.627414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.627414</ArticleId><ArticleId IdType="pmc">PMC7813676</ArticleId><ArticleId IdType="pubmed">33469541</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L, et al. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct. Target. Ther. 2021;6:58. doi: 10.1038/s41392-021-00488-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00488-5</ArticleId><ArticleId IdType="pmc">PMC7873662</ArticleId><ArticleId IdType="pubmed">33568628</ArticleId></ArticleIdList></Reference><Reference><Citation>Prockop DJ. The exciting prospects of new therapies with mesenchymal stromal cells. Cytotherapy. 2017;19:1&#x2013;8. doi: 10.1016/j.jcyt.2016.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2016.09.008</ArticleId><ArticleId IdType="pmc">PMC5154828</ArticleId><ArticleId IdType="pubmed">27769637</ArticleId></ArticleIdList></Reference><Reference><Citation>Connick P, et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol. 2012;11:150&#x2013;156. doi: 10.1016/S1474-4422(11)70305-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70305-2</ArticleId><ArticleId IdType="pmc">PMC3279697</ArticleId><ArticleId IdType="pubmed">22236384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JG, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir. Med. 2015;3:24&#x2013;32. doi: 10.1016/S2213-2600(14)70291-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70291-7</ArticleId><ArticleId IdType="pmc">PMC4297579</ArticleId><ArticleId IdType="pubmed">25529339</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher SA, et al. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database Syst. Rev. 2019;1:CD009768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6353308</ArticleId><ArticleId IdType="pubmed">30697701</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe4;th G, Perakakis N, Mantzoros CS, Seufert J. Stem cells in the treatment of diabetes mellitus - focus on mesenchymal stem cells. Metabolism. 2019;90:1&#x2013;15. doi: 10.1016/j.metabol.2018.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2018.10.005</ArticleId><ArticleId IdType="pubmed">30342065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shende P, Subedi M. Pathophysiology, mechanisms and applications of mesenchymal stem cells for the treatment of spinal cord injury. Biomed. Pharmacother. 2017;91:693&#x2013;706. doi: 10.1016/j.biopha.2017.04.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2017.04.126</ArticleId><ArticleId IdType="pubmed">28499241</ArticleId></ArticleIdList></Reference><Reference><Citation>Borlongan MC, Borlongan MC, Sanberg PR. The disillusioned comfort with COVID-19 and the potential of convalescent plasma and cell therapy. Cell Transpl. 2020;29:963689720940719. doi: 10.1177/0963689720940719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0963689720940719</ArticleId><ArticleId IdType="pmc">PMC7563883</ArticleId><ArticleId IdType="pubmed">32841042</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YJ, et al. Fighting the war against COVID-19 via cell-based regenerative medicine: lessons learned from 1918 Spanish flu and other previous pandemics. Stem Cell Rev. Rep. 2021;17:9&#x2013;32. doi: 10.1007/s12015-020-10026-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10026-5</ArticleId><ArticleId IdType="pmc">PMC7423503</ArticleId><ArticleId IdType="pubmed">32789802</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee RH, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5:54&#x2013;63. doi: 10.1016/j.stem.2009.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2009.05.003</ArticleId><ArticleId IdType="pmc">PMC4154377</ArticleId><ArticleId IdType="pubmed">19570514</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine10.1016/j.eclinm.2021.101019 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bair MJ, Krebs EE. Fibromyalgia. Ann. Intern Med. 2020;172:ITC33&#x2013;ITC48. doi: 10.7326/AITC202003030.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202003030</ArticleId><ArticleId IdType="pubmed">32120395</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin. Proc. Innov. Qual. Outcomes. 2020;4:764&#x2013;766. doi: 10.1016/j.mayocpiqo.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7661943</ArticleId><ArticleId IdType="pubmed">33204998</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickey B, Madhu LN, Shetty AK. Gulf War Illness: mechanisms underlying brain dysfunction and promising therapeutic strategies. Pharmacol. Ther. 2020;24:107716.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8011829</ArticleId><ArticleId IdType="pubmed">33164782</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>